Not applicableStudy completedNCT02884037
What this trial is testing
Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)
Who this might be right for
Non-alcoholic Fatty Liver Disease
Mansoura University 50
Showing 20 of 0 results